Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00498706 · ClinicalTrials.gov registry record · Phase 3

Effectiveness of Telephone Versus Face-to-Face CBT in Treating People With Depression

A Phase 3 study of Depression, sponsored by Northwestern University.

Completed
Registry status
Phase 3
Development phase
325
Enrollment target
1
Study location

NCT00498706: Completed Phase 3 study of Depression, sponsored by Northwestern University.

NCT00498706 is a Phase 3 study of Depression that has completed, run by Northwestern University. The registered enrollment target is 325 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00498706, a Phase 3 study of Depression, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
Phase 3
Development phase
325 participants
Enrollment target
1
Study location

Study Summary

This study will compare the effectiveness of telephone versus face-to-face administration of cognitive behavioral therapy in treating people with depression.

Primary Outcome

Number of therapy sessions attended was collected. At the end of treatment, the total number of sessions attended by each patient was collected.

Conditions Studied

Interventions

  • BEHAVIORAL Telephone-administered cognitive behavioral therapy (T-CBT)
  • BEHAVIORAL Face-to-face administered CBT (FtF-CBT)

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 325 participants
Start Date 2007-12
Est. Completion 2012-05
Phase Phase 3
Northwestern University

1,209 total trials

What the finished NCT00498706 record still lists

NCT00498706 is an interventional study that assigns participants to a tested intervention. The registered 325 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (59% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Telephone-administered cognitive behavioral therapy (T-CBT) is the first listed.

NCT00498706 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00498706 about?

NCT00498706 is a clinical study titled "Effectiveness of Telephone Versus Face-to-Face CBT in Treating People With Depression". This study will compare the effectiveness of telephone versus face-to-face administration of cognitive behavioral therapy in treating people with depression.

What is the current status of trial NCT00498706?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 325 participants. The study started on 2007-12. Estimated completion is 2012-05.

What conditions does trial NCT00498706 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00498706?

The interventions under investigation include: Telephone-administered cognitive behavioral therapy (T-CBT) (BEHAVIORAL), Face-to-face administered CBT (FtF-CBT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00498706?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00498706 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00498706's enrollment target sits among peer trials

325 129th of 679 higher than 550 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03016819 · 325 participants · Phase 3

    Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

  • NCT03288207 · 325 participants · NA

    Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments

  • NCT04986657 · 325 participants · NA

    Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

  • NCT06038318 · 325 participants · NA

    Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00498706, the US trial registry maintained by the National Library of Medicine. NCT00498706 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.